Atsushi Takahashi

发表

Evaluation of Nucleolar Organizer Regions in Human Bladder Cancers by Light- and Electron-Microscopic Morphometry

H. Akaza, Y. Uchiyama, K. Uchida, 1998, European Urology.

Balance of apoptosis and proliferation of germ cells related to spermatogenesis in aged men.

N. Masumori, T. Tsukamoto, M. Kimura, 2003, Journal of andrology.

Recurrence of renal cell carcinoma more than 5 years after nephrectomy

N. Masumori, H. Kitamura, T. Tsukamoto, 2002, International journal of urology : official journal of the Japanese Urological Association.

Identification of a novel large duplication (exon2_6dup): copy number variation in the LDLR gene in a large family with familial hypercholesterolemia by whole-genome sequencing.

K. Hosoda, M. Harada‐Shiba, M. Hori, 2022, Journal of clinical lipidology.

Sarcomatoid transitional cell carcinoma originating from a duplicated renal pelvis

K. Taguchi, H. Iwaki, T. Shimizu, 2001, International journal of urology : official journal of the Japanese Urological Association.

Treatment of invasive bladder cancer: lessons from the past and perspective for the future.

N. Masumori, H. Kitamura, T. Tsukamoto, 2004, Japanese Journal of Clinical Oncology.

Serum testosterone level is a useful biomarker for determining the optimal treatment for castration-resistant prostate cancer.

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2019, Urologic oncology.

Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer

H. Nishiyama, M. Shiota, A. Yokomizo, 2020, BJUI compass.

Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer

R. Saito, M. Tsutsumi, M. Shiota, 2022, Cancer science.

Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer

H. Nishiyama, K. Kuroiwa, M. Shiota, 2021, Cancer science.

Modulation of phenotype of human prostatic stromal cells by transforming growth factor‐betas

Naoya Masumori, Naoki Itoh, Taiji Tsukamoto, 2004, The Prostate.

Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2018, International Journal of Clinical Oncology.

Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC.

Kenya Yamaguchi, M. Oya, Y. Tomita, 2020, Clinical genitourinary cancer.

The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study

N. Nishiyama, N. Masumori, H. Kitamura, 2019, BMC Urology.

Idiopathic stuttering priapism: recovery of detumescence mechanism with temporal use of antiandrogen.

N. Masumori, T. Tsukamoto, R. Kato, 2004, Urology.

Acute normovolemic hemodilution for radical retropubic prostatectomy and radical cystectomy.

N. Masumori, M. Yamakage, T. Tsukamoto, 2008, Urology.

STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.

Naoko Kinukawa, Masatoshi Eto, Seiji Naito, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of docetaxel and prednisolone for castration-resistant prostate cancer: a multi-institutional retrospective study in Japan.

N. Masumori, H. Kitamura, T. Hirose, 2015, Japanese journal of clinical oncology.

Peroxisome proliferator‐activated receptor gamma is frequently underexpressed in renal cell carcinoma

N. Masumori, T. Tsukamoto, N. Itoh, 2006, International journal of urology : official journal of the Japanese Urological Association.

Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.

Y. Tomita, S. Naito, T. Terachi, 2010, European urology.

Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2018, Japanese journal of clinical oncology.

Murine androgen‐independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP

R. Matusik, N. Masumori, Kazunori Kato, 2006, The Prostate.

Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis.

Y. Tomita, O. Ogawa, Kazunari Sato, 2004, Japanese journal of clinical oncology.

Lymph Node Metastasis in Patients with Carcinomas of the Renal Pelvis and Ureter

M. Satoh, N. Masumori, H. Kitamura, 1998, European Urology.

Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.

N. Nishiyama, N. Masumori, H. Kitamura, 2014, Japanese journal of clinical oncology.

Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma

N. Masumori, T. Tsukamoto, N. Miyao, 2003, International journal of urology : official journal of the Japanese Urological Association.

Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.

N. Masumori, T. Tsukamoto, Yoshinori Tanaka, 2002, The Journal of urology.

Treatment for Advanced Testicular Cancer with High‐Dose Chemotherapy and Autologous Blood Stem Cell Transplantation

N. Masumori, S. Sakamaki, T. Tsukamoto, 1998, International journal of urology : official journal of the Japanese Urological Association.

Membrane-Anchored CD14 Is Important for Induction of Interleukin-8 by Lipopolysaccharide and Peptidoglycan in Uroepithelial Cells

N. Masumori, T. Tsukamoto, S. Yokota, 2004, Clinical Diagnostic Laboratory Immunology.

Who needs further evaluations to diagnose upper urinary tract urothelial cancers among patients with abnormal findings by enhanced CT?

F. Fukuta, S. Kato, Shunsuke Sato, 2015, Asian journal of urology.

It is not always necessary for patients with not so severe acute obstructive pyelonephritis due to upper urinary tract calculi to undergo drainage

Masatoshi Muto, F. Fukuta, Yuki Kyoda, 2015 .

Dietary isoflavones may protect against prostate cancer in Japanese men.

N. Miyanaga, H. Akaza, S. Naito, 2007, The Journal of nutrition.

Erectile function following external beam radiotherapy for clinically organ-confined or locally advanced prostate cancer.

M. Hareyama, N. Masumori, T. Tsukamoto, 2004, Japanese journal of clinical oncology.

Clinical safety and feasibility of a newly developed, simple algorithm for decision-making on neurovascular bundle preservation in radical prostatectomy.

Tadashi Hasegawa, Naoya Masumori, Taiji Tsukamoto, 2010, Japanese journal of clinical oncology.

Upper urinary tract recurrence after radical cystectomy for bladder cancer: Incidence and risk factors

N. Masumori, T. Tsukamoto, A. Takahashi, 2012, International journal of urology : official journal of the Japanese Urological Association.

Dietary Isoﬂavones May Protect against Prostate Cancer in Japanese Men 1,2

N. Miyanaga, H. Akaza, S. Naito, 2007 .

Spontaneous regression of primary renal cell carcinoma with inferior vena caval tumor thrombus.

M. Tamakawa, Takashi Sato, K. Sunaoshi, 2002, The Journal of urology.

Characterization of prostatic neuroendocrine cell line established from neuroendocrine carcinoma of transgenic mouse allograft model

N. Masumori, T. Tsukamoto, N. Itoh, 2005, The Prostate.

Therapeutic options to reduce intravesical recurrence in newly diagnosed Ta high‐grade bladder cancer according to risk stratification: A multicenter retrospective study

N. Masumori, Toshiaki Tanaka, S. Hinotsu, 2021, International journal of urology : official journal of the Japanese Urological Association.

Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC)

Tetsuya Shindo, N. Masumori, H. Kitamura, 2014, World Journal of Urology.

Long-term functional outcome and late complications of Studer's ileal neobladder.

N. Masumori, H. Kitamura, Toshiaki Tanaka, 2005, Japanese Journal of Clinical Oncology.

Early and late complications of radical retropubic prostatectomy: experience in a single institution.

N. Masumori, T. Tsukamoto, R. Kato, 2004, Japanese journal of clinical oncology.

Incidence and risk factors of postoperative delirium in elderly patients undergoing urological surgery: A multi‐institutional prospective study

N. Masumori, Toshiaki Tanaka, R. Inoue, 2020, International journal of urology : official journal of the Japanese Urological Association.

Lower urinary tract symptoms of men seeking medical care--comparison of symptoms found in the clinical setting and in a community study.

N. Masumori, T. Tsukamoto, Yoshinori Tanaka, 2003, Urology.

Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2020, Cancer medicine.

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort

H. Nishiyama, O. Ogawa, A. Yokomizo, 2021, Cancer medicine.

Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden

H. Nishiyama, K. Kuroiwa, M. Shiota, 2022, International journal of urology : official journal of the Japanese Urological Association.

[Patients with clinically unconfirmed positive urinary cytology --retrospective analysis of clinical courses].

N. Masumori, T. Tsukamoto, M. Matsukawa, 2007, Hinyokika kiyo. Acta urologica Japonica.

Molecular-targeted Therapy and Surgery May Prolong Survival of Renal Cell Carcinoma Patients with Bone Metastasis: A Multi-institutional Retrospective Study in Japan.

Tetsuya Shindo, N. Masumori, H. Kitamura, 2016, Anticancer research.

Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection.

N. Masumori, H. Kitamura, M. Tamakawa, 2006, Urology.

Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab

H. Nishiyama, O. Ogawa, A. Yokomizo, 2021, International journal of urology : official journal of the Japanese Urological Association.

Modified and bilateral retroperitoneal lymph node dissection for testicular cancer: peri- and postoperative complications and therapeutic outcome.

N. Masumori, H. Kitamura, Toshiaki Tanaka, 2006, Japanese journal of clinical oncology.

Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.

N. Masumori, T. Tsukamoto, N. Itoh, 2004, Urology.

Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients

H. Nishiyama, K. Kuroiwa, M. Shiota, 2020, Cancer science.

Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma.

N. Masumori, H. Kitamura, T. Tsukamoto, 2004, Urology.

Metastatic Cervical Carcinoma Mimicking Kidney Abscess

T. Tsukamoto, E. Hata, H. Adachi, 1998, International journal of urology.

Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study

N. Masumori, S. Hinotsu, R. Kato, 2022, International journal of urology : official journal of the Japanese Urological Association.

A case‐control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet

N. Miyanaga, H. Akaza, T. Fujioka, 2004, Cancer science.

Preselected Biopsy for Normal-Appearing Mucosa of Superficial Bladder Carcinoma

M. Satoh, N. Masumori, T. Tsukamoto, 1998, European Urology.

Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study.

N. Nishiyama, N. Masumori, H. Kitamura, 2018, Urologic oncology.

Paclitaxel, ifosfamide, and nedaplatin as second‐line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group

N. Masumori, H. Kitamura, Toshiaki Tanaka, 2011, Cancer science.

Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.

N. Masumori, T. Hasegawa, T. Tsukamoto, 2008, Japanese journal of clinical oncology.

Recovery of sexual function after nerve‐sparing radical prostatectomy or cystectomy

N. Masumori, H. Kitamura, T. Tsukamoto, 2001, International journal of urology : official journal of the Japanese Urological Association.

Growth rates of primary and metastatic lesions of renal cell carcinoma

N. Masumori, M. Tamakawa, T. Tsukamoto, 2001, International journal of urology : official journal of the Japanese Urological Association.

Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies?

N. Masumori, H. Kitamura, T. Tsukamoto, 2002, International journal of urology : official journal of the Japanese Urological Association.

Sequential therapy of portal vein embolization and systemic chemotherapy for locally advanced perihilar biliary tract cancer.

H. Imamura, A. Saiura, Y. Mise, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Quality of life in patients having an ileal conduit, continent reservoir or orthotopic neobladder after cystectomy for bladder carcinoma

N. Masumori, H. Kitamura, T. Tsukamoto, 1999, International journal of urology : official journal of the Japanese Urological Association.

Bladder cancer discovered by ovarian metastasis: Cytokeratin expression is useful when making differential diagnosis

T. Ikeda, N. Masumori, T. Tsukamoto, 2005, International journal of urology : official journal of the Japanese Urological Association.

Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.

N. Masumori, H. Kitamura, T. Tsukamoto, 2005, Urology.

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

N. Masumori, H. Kitamura, R. Kato, 2015, International journal of urology : official journal of the Japanese Urological Association.

Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2021, Journal of Bone and Mineral Metabolism.

External beam radiation monotherapy for localized or locally advanced prostate cancer.

H. Shirato, M. Hareyama, N. Masumori, 2003, Japanese journal of clinical oncology.

Partial nephrectomy for small localized renal cell carcinoma.

N. Masumori, T. Tsukamoto, M. Yanase, 2004, Hinyokika kiyo. Acta urologica Japonica.

Title Partial nephrectomy for small localized renal cell carcinoma

N. Masumori, M. Yanase, A. Takahashi, 2018 .

Ju External Beam Radiation Monotherapy for Localized or Locally Advanced Prostate Cancer

H. Shirato, M. Hareyama, N. Masumori, 2002 .

[Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection].

N. Masumori, H. Kitamura, T. Tsukamoto, 2005, Hinyokika kiyo. Acta urologica Japonica.

Bone scanning--who needs it among patients with newly diagnosed prostate cancer?

K. Fujimori, N. Masumori, H. Kitamura, 2007, Japanese journal of clinical oncology.

Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.

T. Sugimura, S. Kim, M. Terada, 1994, Cancer research.

Sunitinib versus sorafenib as first-line therapy for patients with metastatic renal cell carcinoma with favorable or intermediate MSKCC risk factors: A multicenter randomized trial, CROSS-J-RCC.

Kenya Yamaguchi, M. Oya, Y. Tomita, 2014 .

Difference in symptom manifestation between postmenopausal and premenopausal women in acute uncomplicated cystitis: A multi-institutional pilot study

N. Masumori, Y. Kunishima, Yuki Kyoda, 2023, Current urology.

[Prognostic factors in patients with metastatic renal cell carcinoma].

N. Masumori, T. Hasegawa, T. Tsukamoto, 2010, Hinyokika kiyo. Acta urologica Japonica.

Characterizationof ProstaticNeuroendocrine Cell Line Established FromNeuroendocrine

N. Masumori, N. Itoh, Atsushi Takahashi, 2004 .

Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma

N. Masumori, H. Kitamura, T. Tsukamoto, 2002, British Journal of Cancer.

Late Recurrence and Second Primary Malignancy among 139 Patients with Germ Cell Tumors: Long-term Outcome of the Disease in a Single-center Experience

N. Masumori, H. Kitamura, Toshiaki Tanaka, 2009, Japanese journal of clinical oncology.

Efficacy and safety of docetaxel and prednisolone for castration-resistant prostate cancer: a multi-institutional retrospective study in Japan.

N. Masumori, H. Kitamura, T. Hirose, 2015, Japanese journal of clinical oncology.

Interleukin-6 in renal cell carcinoma.

N. Masumori, T. Tsukamoto, N. Miyao, 1992, The Journal of urology.

Long-term outcome of chemotherapy for advanced testicular and extragonadal germ cell tumors: a single-center 27-year experience.

N. Masumori, H. Kitamura, Toshiaki Tanaka, 2010, Japanese journal of clinical oncology.

Risk factors for multiple intravesical recurrences of superficial bladder cancer.

N. Masumori, T. Tsukamoto, N. Miyao, 2001, Urology.

Sunitinib versus sorafenib as first-line therapy followed by sorefenib and sunitinib for patients with metastatic renal cell carcinoma (RCC) with clear cell histology: A multicenter randomized trial, CROSS-J-RCC.

Kenya Yamaguchi, M. Oya, Y. Tomita, 2017 .